Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42 beta-amyloids

International Journal of Biochemistry and Cell Biology

Volumn 44, Issue 11, 2012, Pages 2085-2093

  Galante, Denise ^a   Corsaro, Alessandro ^b   Florio, Tullio ^b   Vella, Serena ^c   Pagano, Aldo ^c   Sbrana, Francesca ^a   Vassalli, Massimo ^a   Perico, Angelo ^a   D'Arrigo, Cristina ^a  

^a CNR   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Aggregation process; Alzheimer disease; Beta amyloids; Neurotoxicity; Oligomer states

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[PY3-42]; LIPOCORTIN 5; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; BETA SHEET; CIRCULAR DICHROISM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FAST PROTEIN LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE MICROSCOPY; INTERNALIZATION; MOLECULAR WEIGHT; MORPHOLOGY; NEUROBLASTOMA CELL; NEUROTOXICITY; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN STRUCTURE; TRANSMISSION ELECTRON MICROSCOPY;

AMYLOID BETA-PEPTIDES; CELL DEATH; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCULAR DICHROISM; ENDOCYTOSIS; HUMANS; MICROSCOPY, FLUORESCENCE; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; TIME FACTORS;

EID: 84865613114     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2012.08.010     Document Type: Article

References (50)

1. M.M. Apetri, N.C. Maiti, M.G. Zagorski, P.R. Carey, and V.E. Anderson Secondary structure of alpha-synuclein oligomers. Characterization by Raman atomic force microscopy Journal of Molecular Biology 355 2006 63 71
2. S. Campioni, B. Mannini, M. Zampagni, A. Pensalfini, C. Parrini, and E. Evangelisti A causative link between the structure of aberrant protein oligomers and their toxicity Nature Chemical Biology 6 2010 140 147
3. K. Chiovitti, A. Corsaro, S. Thellung, V. Villa, D. Paludi, and C. D'Arrigo Intracellular accumulation of a mild-denatured monomer of the human PrP fragment 90-231, as possible mechanism of its neurotoxic effects Journal of Neurochemistry 103 2007 2597 2609
4. F. Chiti, N. Taddei, F. Baroni, C. Capanni, M. Stefani, and G. Ramponi Kinetic partitioning of protein folding and aggregation Natural Structural Biology 9 2002 137 143
5. F. Chiti, and C.M. Dobson Protein misfolding, functional amyloid, and human disease Annual Review of Biochemistry 75 2006 333 366
6. A. Corsaro, S. Thellung, V. Villa, D.R. Principe, D. Paludi, and S. Arena Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation Annals of the New York Academy of Sciences 1010 2003 610 622
7. A. Corsaro, S. Thellung, T. Bucciarelli, L. Scotti, K. Chiovitti, and V. Villa High hydrophobic amino acid exposure is responsible of the neurotoxic effects induced by E200K or D202N disease-related mutations of the human prion protein International Journal of Biochemistry and Cell Biology 43 2011 372 382
8. C. D'Arrigo, M. Tabaton, and A. Perico N-terminal truncated pyroglutamyl β amyloid peptide Aβpy3-42 shows a faster aggregation kinetics than the full-length Aβ1-42 Biopolymers 91 2009 861 873
9. S. Diemert, A.M. Dolga, S. Tobaben, J. Grohm, S. Pfeifer, and E. Oexler Impedance measurement for real time detection of neuronal cell death Journal of Neuroscience Methods 203 2012 69 77
10. T. Florio, S. Thellung, C. Amico, M. Robello, M. Salmona, and O. Bugiani Prion protein fragment 106-126 induces apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in the GH3 cell line Journal of Neuroscience Research 54 1998 341 352
11. T. Florio, D. Paludi, V. Villa, D.R. Principe, A. Corsaro, and E. Millo Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxic Journal of Neurochemistry 85 2003 62 72
12. G. Forloni, L. Terreni, I. Bertani, S. Fogliarino, R. Invernizzi, and A. Assini Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms Neurobiology of Aging 23 2002 957 976
13. S. Ghatan, S. Larner, Y. Kinoshita, M. Hetman, L. Patel, and Z. Xia p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons Journal of Cell Biology 150 2000 335 347
14. M.L. Giuffrida, F. Caraci, P. De Bona, G. Pappalardo, F. Nicoletti, and E. Rizzarelli The monomer state of β-amyloid: where the Alzheimer's disease protein meets physiology Reviews in the Neurosciences 21 2010 83 93
15. W. He, and C.J. Barrow The Aβ 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater β-sheet forming and aggregation propensities in vitro than full-length Aβ Biochemistry 38 1999 10871 10877
16. L.W. Hung, G.D. Ciccotosto, E. Giannakis, D.J. Tew, K. Perez, and C.L. Masters Amyloid-β peptide (Aβ) neurotoxicity is modulated by the rate of peptide aggregation: Aβ dimers and trimmers correlate with neurotoxicity Journal of Neuroscience 28 2008 11950 11958
17. S. Jawhar, O. Wirths, and T.A. Bayer Pyroglutamate amyloid-β: a hatchet man in Alzheimer disease Journal of Biological Chemistry 286 2011 38825 38832
18. M. Jin, N. Shepardson, T. Yang, G. Chen, D. Walsh, and D.J. Selkoe Soluble amyloid β-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration Proceedings of the National Academy of Sciences of the United States of America 108 2011 5819 5824
19. N. Ke, X. Wang, X. Xu, and Y.A. Abassi The xCELLigence System for real-time and label-free monitoring of cell viability Methods in Molecular Biology 740 2011 33 43
20. Y.P. Li, A.F. Bushnell, C.M. Lee, L.S. Perlmutter, and S.K. Wong β-Amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells Brain Research 738 1996 196 204
21. C. Manzoni, L. Colombo, P. Bigini, V. Diana, A. Cagnotto, and M. Messa The molecular assembly of amyloid Aβ controls its neurotoxicity and binding to cellular proteins PLoS One 6 2011 e24909
22. I.A. Mastrangelo, M. Ahmed, T. Sato, W. Liu, C. Wang, and P. Hough High-resolution atomic force microscopy of soluble Aβ42 oligomers Journal of Molecular Biology 358 2006 106 119
23. B.D. Moore, V. Rangachari, M.W. Tay, N.M. Milkovic, and T.L. Rosenberry Biophysical analyses of synthetic amyloid-β (1-42) aggregates before and after covalent cross-linking. Implications for deducing the structure of endogenous amyloid-β oligomers Biochemistry 48 2009 11796 11806
24. H. Mori, K. Takio, M. Ogawara, and D.J. Selkoe Journal of Biological Chemistry 267 1992 17082 17086
25. R. Moriya, T. Uehara, and Y. Nomura Mechanism of nitric oxide-induced apoptosis in human neuroblastoma SH-SY5Y cells FEBS Letters 484 2000 253 260
26. K. Ono, M.M. Condron, and D.B. Teplow Structure-neurotoxicity relationships of amyloid β-protein oligomers Proceedings of the National Academy of Sciences of the United States of America 106 2009 14745 14750
27. S. Påhlman, J.C. Hoehner, E. Nånberg, F. Hedborg, S. Fagerström, and C. Gestblom Differentiation and survival influences of growth factors in human neuroblastoma European Journal of Cancer 31A 1995 453 458
28. A. Perico, D. Galante, and C. D'Arrigo Structure and Toxicity of the Prefibrillar Aggregation States of Beta Peptides in Alzheimer's Disease, Chapter 8 of INTECH Book S. de La Monte, Alzheimer's Disease Pathogenesis 2011 157-172
29. M.T. Pastor, N. Kummerer, V. Schubert, A. Esteras Chopo, F.C.G. Dotti, and M. Lopez de la Paz Amyloid toxicity is independent of polypeptide sequence, length and chirality Journal of Molecular Biology 375 2008 695 707
30. R. Roychaudhuri, M. Yang, M.M. Hoshi, and D.B. Teplow Amyloid β protein assembly and Alzheimer disease Journal of Biological Chemistry 284 2009 4749 4753
31. C. Russo, G. Schettini, T.C. Saido, C. Hulette, C. Lippa, and L. Lannfelt Presenilin-1 mutations in Alzheimer's disease Nature 405 2000 531 532
32. C. Russo, E. Violani, F. Salis, V. Venezia, V. Dolcini, and G. Damonte Pyroglutamate-modified amyloid β peptides AβN3(pE) strongly affect cultured neuron and astrocyte survival Journal of Neurochemistry 82 2002 1480 1489
33. T.C. Saido, T. Iwatsubo, D.M. Mann, H. Shimada, Y. Ihara, and S. Ka-washima Neuron 14 1995 457 466
34. A. Sandberg, L.M. Luheshi, S. Sollvander, T. Pereira de Barros, B. Macao, and T.P.J. Knowles Stabilization of neurotoxic Alzheimer amyloid-β oligomers by protein engineering Proceedings of the National Academy of Sciences of the United States of America 107 2010 15595 15600
35. H. Schagger, and G. Von Jagow Tricine-sodium dodecyl sulfate- polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa Analytical Biochemistry 166 1987 368 379
36. D.J. Selkoe Amyloid β-protein and the genetics of Alzheimer's disease Journal of Biological Chemistry 271 1996 18295 18298
37. D.J. Selkoe Alzheimer disease: mechanistic understanding predicts novel therapies Annals of Internal Medicine 140 2004 627 638
38. M.S. Shearman Toxicity of protein aggregates in PC12 cells: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay Methods in Enzymology 309 1999 716 723
39. S. Schilling, T. Hoffmann, S. Manhart, M. Hoffmann, and H.U. Demuth Glutaminyl cyclase unfold glutamyl cyclase activity under mild acid conditions FEBS Letters 563 2004 191 196
40. S. Schilling, T. Lauber, M. Schaupp, S. Manhart, E. Scheel, and G. Bohm On the seeding and oligomerization of pGlu-amyloid peptides Biochemistry 45 2006 12393 12399
41. S. Shilling, U. Zeitschel, T. Hoffmann, U. Heiser, M. Francke, and A. Kehlen Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology Nature Medicine 14 2008 1106
42. T.L. Tekirian, A.Y. Yang, C. Glabe, and J.W. Geddes Toxicity of pyroglutaminated amyloid β-peptides 3(pE)-40 and -42 is similar to that of Aβ1-40 and -42 Journal of Neurochemistry 73 1999 1584 1589
43. S. Thellung, V. Villa, A. Corsaro, S. Arena, E. Millo, and G. Damonte p38 MAP kinase mediates the cell death induced by PrP106 126 in the SH-SY5Y neuroblastoma cells Neurobiology of Disease 9 2002 69 81
44. S. Thellung, A. Corsaro, V. Villa, A. Simi, S. Vella, and A. Pagano Human PrP90-231-induced cell death is associated with intracellular accumulation of insoluble and protease-resistant macroaggregates and lysosomal dysfunction Cell Death & Diseases 2 2011 e138
45. D.M. Walsh, A. Lomakin, G.B. Benedek, M.M. Condron, and D.B. Teplow Amyloid β-protein fibrillogenesis. Detection of a protofibrillar intermediate Journal of Biological Chemistry 272 1997 22364 222372
46. D.M. Walsh, D.M. Hartley, Y. Kusumoto, Y. Fezoui, M.M. Condron, and A. Lomakin Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates Journal of Biological Chemistry 274 1999 25945 25952
47. O. Wirths, H. Breyhan, H. Cynis, S. Schilling, H.U. Demuth, and T.A. Bayer Acta Neuropathologica 118 2009 487 496
48. O. Wirths, C. Erck, H. Martens, A. Harmeier, C. Geumann, and S. Jawhar Identification of low molecular weight pyroglutamate Aβ oligomers in Alzheimer disease: a novel tool for therapy and diagnosis Journal of Biological Chemistry 285 2010 41517 41524
49. M. Wogulis, S. Wright, D. Cunningham, T. Chilcote, K. Powell, and R.E. Rydel Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death Journal of Neuroscience 25 2005 1071 1080
50. Y. Yoshiike, T. Akagi, and A. Takashima Surface structure of amyloid-β fibrils contributes to cytotoxicity Biochemistry 46 2007 9805 9812